9 Crohns Disease Clinical Trials in Colorado Springs, CO (2026)

Q: How do I join a clinical trial in Colorado Springs?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you.

Recruiting Crohns Disease Studies in Colorado Springs

NCT07184944Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Croh...

Colorado Springs, COPHASE3751 participantsSanofi

View Study Details

NCT06548542Recruiting

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms i...

Colorado Springs, COPHASE2540 participantsAbbVie

View Study Details

NCT07499232Recruiting

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing sev...

Colorado Springs, COPHASE3530 participantsJanssen Research & Development, LLC

View Study Details

NCT07577843Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn'...

Colorado Springs, COPHASE3460 participantsJanssen Research & Development, LLC

View Study Details

NCT06819891Recruiting

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known as RO7790121) in participants with moderately...

Colorado Springs, COPHASE3425 participantsHoffmann-La Roche

View Study Details

NCT06227910Recruiting

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to ved...

Colorado Springs, COPHASE3396 participantsTakeda

View Study Details

NCT06226883Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately...

Colorado Springs, COPHASE2385 participantsMorphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

View Study Details

NCT06456593Recruiting

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared t...

Colorado Springs, COPHASE2212 participantsAbivax S.A.

View Study Details

NCT07113522Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the saf...

Colorado Springs, COPHASE2140 participantsMirador Therapeutics, Inc.

View Study Details

About Crohns Disease Clinical Trials in Colorado Springs

Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.

There are currently 9 crohns disease clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 3,839 participants. Research is being sponsored by Sanofi, AbbVie, Janssen Research & Development, LLC and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Crohns Disease Clinical Trials in Colorado Springs — FAQ

Are there crohns disease clinical trials in Colorado Springs?

Yes, there are 9 crohns disease clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What crohns disease treatments are being tested?

The 9 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.

Data updated July 17, 2026 from ClinicalTrials.gov